Intratympanic Injection: Clinical Trials

1 trial for Intratympanic Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Intratympanic Injection: new trials by email Literature Review of Intratympanic Injection trials Research Report on Intratympanic Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
Dexamethasone, Hyaluronic acid, Indocyanine green(ICG) - Hearing Loss, Sensorineural, Hearing Loss, Sudden
Phase 1 / Phase 2WithdrawnSeoul National University Hospital2026-12-152026-05-22

Narrower conditions

Hearing Loss, Sensorineural (1)  ·  Hearing Loss, Sudden (1)

Broader conditions

Ear Diseases (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Dexamethasone (1)  ·  Hyaluronic Acid (1)  ·  Indocyanine Green (1)

Sponsors

Seoul National University Hospital (1)